Clinical Trials Browser

Not yet recruiting × NETWORK × Immunotherapy, Adoptive × Clear all

NCT07341191 2026-02-12

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Phase 2 Not yet recruiting

Recurrence, Lymphoma, Mantle-Cell